1. Home
  2. WSR vs CMPX Comparison

WSR vs CMPX Comparison

Compare WSR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Whitestone REIT

WSR

Whitestone REIT

HOLD

Current Price

$18.98

Market Cap

973.9M

Sector

Real Estate

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.90

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSR
CMPX
Founded
1998
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
973.9M
927.5M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
WSR
CMPX
Price
$18.98
$1.90
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
$19.00
$14.57
AVG Volume (30 Days)
366.7K
11.9M
Earning Date
05-01-2026
05-06-2026
Dividend Yield
3.01%
N/A
EPS Growth
31.94
N/A
EPS
0.08
N/A
Revenue
$160,859,000.00
N/A
Revenue This Year
$2.77
N/A
Revenue Next Year
$4.21
$934.41
P/E Ratio
$237.19
N/A
Revenue Growth
4.26
N/A
52 Week Low
$11.43
$1.61
52 Week High
$19.01
$6.88

Technical Indicators

Market Signals
Indicator
WSR
CMPX
Relative Strength Index (RSI) 79.23 29.84
Support Level $18.90 $1.61
Resistance Level $19.00 $2.02
Average True Range (ATR) 0.03 0.13
MACD -0.09 0.11
Stochastic Oscillator 41.67 64.81

Price Performance

Historical Comparison
WSR
CMPX

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) that owns and operates commercial properties in culturally diverse metropolitan markets. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business-friendly locations in and around Austin, Scottsdale, Dallas, Houston, Phoenix, Arizona, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: